Shares of Hims & Hers Tumble 23% After FDA Says semaglutide is no longer in shortage
Shares of Hims & Hers Health Tumbled more than 23% on Friday after the US Food and Drug Administration announced That the shortage of semaglutide injection products have been resolved. Semaglutide is the active ingredient in Novo Nordisk‘S Blockbuster Weight Loss Drug Wegovy and Diabetes Treatment OzEMPIC. Thos medicines are part of a class of … Read more